Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
influenza vaccine
Biotech
Blackstone bets $750M on Moderna's flu program
Blackstone is making a $750 million bet on Moderna’s flu program as part of the investment platform’s push to “support innovative mRNA technology.”
James Waldron
Mar 27, 2024 8:54am
Researchers find new flu antibodies that could improve vaccines
Dec 22, 2023 4:32pm
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial
Oct 31, 2023 7:53am
Moderna's one-two COVID-flu punch matches existing vaccines
Oct 4, 2023 9:55am
After initial stumbles, Moderna gets clean win for mRNA flu shot
Sep 13, 2023 6:30am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am